Zobrazeno 1 - 3
of 3
pro vyhledávání: '"23-hydroxybetulinic acid derivative"'
Autor:
Nan Yao, Ying-Jie Li, Dong-Mei Zhang, Dao-Lu Liu, Ming-Kuen Tang, Anita Yiu, Yong Li, Wei-Min Chen, Ping Lan, Zhe Yao, Zhe-Sheng Chen, Wen-Cai Ye
Publikováno v:
Cellular Physiology and Biochemistry, Vol 37, Iss 3, Pp 838-852 (2015)
Background/Aims: Hepatocellular carcinoma (HCC) is the most common type of liver cancer. At present, only sorafenib is approved to treat HCC. In this study, we found that a 23-hydroxybetulinic acid derivative, B4G2, exhibited potent antiproliferative
Externí odkaz:
https://doaj.org/article/e3d11e312516482aad395f3946341d4f
Autor:
Ming-Kuen Tang, Nan Yao, Wei-Min Chen, Ping Lan, Yong Li, Zhe Yao, Dao-Lu Liu, Ying-Jie Li, Zhang Dongmei, Ye Wencai, Zhe-Sheng Chen, Anita Yiu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 37, Iss 3, Pp 838-852 (2015)
Background/Aims: Hepatocellular carcinoma (HCC) is the most common type of liver cancer. At present, only sorafenib is approved to treat HCC. In this study, we found that a 23-hydroxybetulinic acid derivative, B4G2, exhibited potent antiproliferative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ef4a2680c41398774f1d7ed961b392
https://pubmed.ncbi.nlm.nih.gov/26382946
https://pubmed.ncbi.nlm.nih.gov/26382946
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.